STOCK EXCHANGE INTIMATION

2024-2025

 
 
 
 
 
 
 
 
 
 
 
 
 

Offer-Opening Advertisement cum Corrigendum to the Letter of Offer

Letter of offer dated 13/09/2024

Summary of AGM Proceedings dated 12.08.2024

Changes in Senior Management Personnel of the Company dated 09082024

Earning call transcript for Q1

Voting Results of 27th AGM dated August 12,2024

Earning Presentation Q1 Audio Link 

Outcome of Board Meeting dated August 09, 2024

Intimation of Schedule of Investors Meet/ Conference dated August 13, 2024 and August 14, 2024

Q1 Earning Conference Call Invite’ dated August 09, 2024

Revised record date for the interim dividend 2024-25

Post AGM Notice Dispatch Advertisement

Pre AGM Notice Advertisement

Business Responsibility And Sustainability Report FY 2023-24

Annual Report and Notice of  27th AGM

Reconciliation of share capital audit report for Quarter and year ended June 30,2024

Changes in Senior Management Personnel of the Company

Investor Grievance Report (30-06-2024)

SDD Compliance Certificate for Quarter ended June 30,2024

Disclosure under Regulation 74(5) of SEBI (Depositories and Participants) Regulations,2018 for Quarter ended June 30 ,2024

Intimation of Trading Window Closure

Change in Directorate

Investor Presentation (18-06-2024)

Newspaper advertisement on Notice of transfer of equity shares of the Company to IEPF

Intimation of Schedule of Investors Meet/ Conference dated June 18, 2024 and June 19, 2024

Reg.24(A)-Annual Secretarial Compliance Report for FY ended March 31,2024

Intimation Of Change In Investor Relation Agency Of The Company  dated April 30, 2024

2023-2024

Business Responsibility and Sustainability Report

Earning call Transcript Q4

Earning Presentation Q4 Audio Link

Disclosure of Related Party Transaction for the half year ended March 31, 2024

Outcome of Board Meeting Dated May 28, 2024

Q4 Earning Conference Call Invite’ dated May 24,2024

Certificate under Regulation 74(5) of SEBI (Depository and Participants) Regulations, 2018

Certificate under Regulation 40(9) & 40(10) of SEBI (LODR) Regulations, 2015 for FY ended 2024

Voting Results of Postal ballot notice dated 26th March, 2024

Intimation of Scrutinizer’s Report dated April 29, 2024

Reconciliation of share capital audit report for Quarter and year ended March 31,2024

Intimation of Board Meeting date May 28, 2024

Certificate under Regulation 7(3) of SEBI (LODR) Regulations, 2015 for FY ended 2024

SDD Compliance Certificate for Quarter ended March 31,2024

Closure of trading window for the quarter and year ended March 31, 2024

Newspaper Publication of Notice of Postal Ballot dated March 26, 2024

Notice of Postal Ballot dated March 26, 2024

Reconstitution of Committees dated March 26, 2024

Intimation of Review of Credit Rating

Intimation of Schedule of Investors Meet/ Conference dated March 26, 2024

Investor Grievance Report (31-12-2023)

Disclosure under Regulation 74(5) of SEBI (Depositories and Participants) Regulations,2018 for Quarter ended December 31,2023

Earning Call Transcript Q3

Outcome of Board Meeting held on February 05, 2024

Resignation of Independent director dated February 05, 2024

Appointment of Independent directors dated February 05, 2024

Reg.24(A)-Annual Secretarial Compliance Report

SDD Compliance Certificate for Quarter ended December 31,2023

Disclosure under Regulation 74(5) of SEBI (Depositories and Participants) Regulations,2018 for Quarter ended December 31,2023

SDD Compliance Certificate for Quarter ended December 31,2023

Investor Grievance for Quarter ended December 31,2023

Reconciliation of share capital audit report for Quarter ended December 31,2023

Closure of trading window and intimation of Board Meeting for consideration of financial results for the quarter and nine months ended December 31, 2023

Intimation under regulation 10(5) of SEBI (Substantial Acquisition of shares and Takeover) Regulations, 2011 (“Takeover Regulations”) in respect of the
Acquisition under Regulation 10(1)(a) of the Takeover Regulations.

Intimation of receipt of PATENT (A NOVEL ISOXAZOLE COMPOUND OR A SALT THEREOF)

Intimation of Schedule of Investors Meet/ Conference dated December 13, 2023

Clarification on Price Movement sought by NSE

Clarification on Price Movement sought by BSE

Earning Call Transcript Q2′ dated November 08, 2023

Intimation of Schedule of Analyst Meeting under SEBI (Listing Obligations And Disclosure Requirements) Regulations,2015 dated November 02, 2023

Intimation of Schedule of Analyst Meeting under SEBI (Listing Obligations And Disclosure Requirements) Regulations,2015 dated November 01, 2023

Outcome of BOARD Meeting held on November 02, 2023

Reconciliation Of Share Capital Audit Report’ dated October 11, 2023

Disclosure pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for Quarter ended September 30,2023

Voting Results of 26th AGM dated September 23, 2023

‘Intimation of Schedule of Analyst Meeting under the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015 dated September 23,2023

Outcome of 26th AGM dated September 23,2023

Intimation Under Regulation 30 of SEBI(LODR) Regulation,2015 dated September 08,2023

Newspaper Publication of Notice of 26th AGM

Annual Report of FY 2022-23 containing Notice of the 26th AGM

Business Responsibility and Sustainability Report for FY 2022-23

Intimation of Investor Meet (August 28,2023)

Earning Call Transcript Q1

Newspaper advertisement on Extract of Unaudited Financial Results for the Quarter ended June 30, 2023

Outcome of Board Meeting held on August 10,2023

Acquisition of Industrial Site

Intimation of receipt of PATENT (SUBSTITUTED PYRAZOLE DERIVATIVES AND INSECTICIDES AND FUNGICIDES)

SDD Compliance Certificate for quarter ended June,2023

Disclosure under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for Quarter Ended June 30, 2023.

Closing Of Trading Window, June 2023

Investor Grievance Report(30-06-2023)

Reconciliation of Share Capital Audit Report

Intimation of Board Meeting, dated July,18 2023

RPT_Report

Outcome of Board Meeting held on May 30, 2023

2022-2023

Intimation of Book Closure and Record date for Final Divided for Financial Year 2021-2022 dated September 09,2022

Disclosure of Related Party Transactions for the year ended March 31, 2022

Disclosure pursuant to Regulation 46 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 dated August 30,2022

Receipt of PATENT (NOVEL FUNGICIDAL CARBAMATE COMPOUNDS) dated July 09,2022′

Outcome of Board Meeting dated May 26,2022

Disclosure of Related Party Transactions for the year ended September 30, 2022

Closure of trading window dated december 30,2022′

Disclosure persuant to regulation 42 of SEBI(LODR) Regulations,2015 dated september 17,2022′

Proceedings of 25th AGM dated september 23,2022

Scrutinizer’s report dated september 25,2022

Notice of 25th AGM along with annual report dated September 02,2022

Publication of Q4 Results

Intimation of Book Closure and Record date for Final Dividend for Financial Year 2021-2022 

Intimation pursuant to Regulation 30 of the SEBI (LODR) 2015 – Allotment of Bonus Equity Shares

Intimation Of Incorporation Of A Wholly-Owned Subsidiary Of the Company

Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 

Certificate under Regulation 7(3) of SEBI (LODR) Regulations, 2015 for FY ended 2023.

Certificate under Regulation 40(9) & 40(10) of SEBI (LODR) Regulations, 2015 for FY ended 2023.

Disclosure under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for Quarter Ended March 31, 2023.

Closure of Trading Window, March 2023

Outcome of Board Meeting held on 13th February, 2023

Newspaper Publication for Financial Results for Quarter ended December 31, 2022

Compliance Certificate for the Quarter ended December 31, 2022

Disclosure pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018

Intimation of Review of Credit Rating

Newspaper advertisement on Notice of transfer of equity shares of the Company to IEPF

Investor Presentation November

Outcome of Board Meeting held on 07/11/2022

Compliance Certificate for the Quarter Ended September 30, 2022

Reconciliation of Share Capital Audit Report

Closure of Trading Window, September, 2022

Certificate under Regulation 74(5) of SEBI (Depository and Participants) Regulations, 2018

Intimation of Board Meeting dates October 18,2022

Rectification Of Item Number 2.A) Of The Outcome Of The Board Meeting Held On August 20, 2022

Outcome of Board Meeting held on August 20, 2022

Compliance Certificate for The Quarter Ended June 2022

Outcome of Board Meeting held on August 12, 2022

Newspaper advertisement on Notice of transfer of equity shares of the Company to IEPF.Closure of Trading Window

Closure of Trading Window

Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s

Reg.24(A)-Annual Secretarial Compliance Report

Outcome of Board meeting

Intimation for Conference Call for Q4 & FY 22

Receipt of Patent (Novel Granules and its Pesticidal Compositions)Receipt of Patent (Novel Miticidal Benzylamides)

Receipt of Patent (Novel Miticidal Benzylamides)

Receipt of Patent (Novel Dithiolane Compound or a Salt or an N-Oxide and use thereof)